Login

Healthcare

00:00:00
Eduardo Baviera Sabater, CEO, Clinica Baviera
00:00:00
CEO TALK - Yakov Kogan, CEO, Cleveland BioLabs
00:00:00
Commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases. - Leonard Mazur, CEO, Citius Pharmaceuticals
00:00:00
Cipher Pharmaceuticals (TSX: CPH) Update with Craig Mull - CEO, Cipher Pharmaceuticals Inc
00:00:00
Checkpoint Therapeutics aiming to be phase 3 ready - James F. Oliviero President & Chief Executive Officer, Checkpoint Therapeutics Inc
00:00:00
Cerenis Therapeutics is specialized in research & development into HDL - Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics
00:00:00
Cello Health 'making good headway' with decent organic growth - Mark Scott, chief executive of Cello Health plc
00:00:00
Development of a mobile system for managing type 1 diabetes - Eric Beard, Chairman and CEO of Cellnovo Group
00:00:00
Cellmid expanding products, portfolio and markets - Maria Halasz , CEO, Cellmid Ltd
00:00:00
CEL-SCI Corp letter to shareholders details positive results from Phase 3 study of Multikine - Geert R. Kersten Director and Chief Executive Officer, CEL-SCI Corp
00:00:00
Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro
00:00:00
Predictive modeling driven behavioral healthcare services to health plans - Terren Peizer, Chairman & CEO of Catasys, Inc.
00:00:00
Developing transformative cell and exosome-based therapeutics to treat muscular diseases - Linda Marbán, Ph.D. Chief Executive Officer and Director, Capricor Therapeutics Inc
00:00:00
Cantargia's CEO Göran Forsberg presents the company- Göran Forsberg, CEO, Cantargia
00:00:00
Rav Mlait, MBA CEO, Director, Cannabix Technologies Inc
00:00:00
Test target cancers that are difficult to diagnose - Panna Sharma, CEO, Cancer Genetics Inc

© 2026 Nehu